Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer
Clinical trial NCT07005583 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07005583
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2027-05-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.